MEN1 and diffuse large B-cell lymphoma: Indeed, we demonstrated that genetic or pharmacologic inhibition of MEN1 could phenocopy the effects of PRC2 knockout in inhibiting the proliferation of EZH2 mutant and/or H3K27me3-high DLBCL and MM cells (Fig. 3).